CIHR China-Canada Joint Health Research Initiative

Background

The program, established in 2005, is jointly managed and funded by the Canadian Institutes of Health Research (CIHR) and the National Natural Science Foundation of China (NSFC). Its aim is to promote the development of Canadian-Chinese scientific co-operation between universities, hospitals, research institutes or affiliated research organizations in Canada and China through the support of collaborative research grants.

Objectives

CIHR and NSFC will provide funding for applications that are determined to be relevant to the following research areas:

• Aging, Gerontology and Geriatrics: to encourage research on aging processes, on functional limitations in older adults as a consequence of disease, and on determinants of healthy aging within the context of one or more of the following priority areas: healthy and successful aging, biological mechanisms of aging, cognitive impairment in aging, aging and maintenance of functional autonomy, and health services related to older people.
• Cancer: to provide support for research on cancer genetics, biomarkers and epigenetics; tumour micro-environment, inflammation and metastasis.
• Cardiovascular System: to provide support for basic and translational research on the pathogenesis, treatment and ultimate cure of cardiovascular diseases, including myocardial infarction, stroke, cardiomyopathy and atherosclerosis.
• Child and Youth Health: to provide support for research on fertility, pregnancy, maternal health, healthy child development and the etiology, prevention, and treatment of diseases in infants, children and youth.
• Diabetes and Obesity: to provide support for research on the measures, causes, prevention, treatment and consequences of diabetes and obesity.
• Gender and Health: to provide support for research that addresses how sex (biological characteristics) and gender (socially constructed roles and relationships) influence the health of women and men, girls and boys throughout life.
• Genetics: to provide support for research on the human and other genomes and on all aspects of genetic, basic biochemistry and cell biology related to health and disease.
• Infection and Immunity: to provide support for research in the field of infection and immunity.
• Musculoskeletal Health and Arthritis: to provide support on one or more of the three strategic priorities such as: physical activity, mobility and health; tissue injury, repair and replacement; pain, disability and chronic disease.
• Neurosciences: to provide support for basic research in neurosciences, mental health, addiction and the senses.
• Population and Public Health: To provide support for population and public health research that aims to compare how different policies and/or primary health care delivery models shift the distribution of health and illness in different contexts.
• Respiratory health: to support basic and translational research in respiratory disease including asthma, chronic obstructive pulmonary disease and acute lung injury, with particular emphasis on better understanding the pathogenesis and facilitating the early detection of airway disease or lung injury.

Eligibility

Each application must have a Principal Applicant from each of Canada and China.

For the Canadian component of the application to be considered eligible:

1. The Nominated Principal Applicant must be an independent researcher registered at an eligible institution.
2. At least one project participant must be an independent researcher from China (i.e., must hold a faculty position in a university or a research institute in China) and must be listed as a Principal Applicant.
3. Co-Applicants must be one of the following (inclusion of one or more Co-applicants is optional):
   •    An independent researcher
   •    A trainee

For the Chinese component of the application to be considered eligible, applicants must refer to the NSFC website for further details.

Note:  Individuals cannot be a Principal Applicant on more than one on-going grant through the China-Canada Joint Health Research Initiative.

Randomized Controlled Trials

Randomized Controlled Trials (RCT) will not be considered under this funding opportunity.

Funding Available

• The total amount available for this funding opportunity is C$3,375,000 from CIHR and 15,000,000 RMB from NSFC.
• For Canada-based researchers, the maximum amount awarded for a single grant is up to C$75,000 per year for up to three years.
• For China-based researchers, the maximum amount awarded for a single grant is the equivalent of up to 333,333 RMB per year for up to three years.

Full details on the CIHR Canada-China Joint Health Research Initiative

Deadlines

CURO Checklist and Instructions for faculty submissions

Internal Contacts

If you are interested in this opportunity, please contact:

• your Research Facilitator or Carleton International for help with proposal development and substantive review

Tuesday, February 5, 2013  |  Categories: Funding Opportunities
Share: Twitter, Facebook
Short URL: https://carleton.ca/ci/?p=1791